Conatus Pharma to explore options as liver disease drug fails trial

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jun 24, 2019 at 7:32 PM.

  1. #1 cafead, Jun 24, 2019 at 7:32 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,013
    Likes Received:
    3
    via Conatus Pharmaceuticals Inc said on Monday it plans to explore options and implement a restructuring plan after its liver disease drug failed in a mid-stage trial.

    The drug developer's shares halved to 48 cents after the bell.

    article source
     
    Quote

Reply to Thread